Response to "No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study".

Desai, Deesha; Sikora, Michelle; Nohria, Ambika; Caplan, Avrom S; Lacouture, Mario; Shapiro, Jerry; Lo Sicco, Kristen I

Desai, Deesha; Sikora, Michelle; Nohria, Ambika; Caplan, Avrom S; Lacouture, Mario; Shapiro, Jerry; Lo Sicco, Kristen I.

Afiliação

Desai D; University of Pittsburgh School of Medicine, Pittsburgh, PA; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY. Electronic address: deesha.desai@nyulangone.org.
Sikora M; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY; New York Medical College, Valhalla, NY.
Nohria A; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY.
Caplan AS; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY.
Lacouture M; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY.
Shapiro J; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY.
Lo Sicco KI; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY.

J Am Acad Dermatol ; 2024 Aug 19.

Article em En | MEDLINE | ID: mdl-39168312